08:00 , Jan 21, 2013 |  BC Week In Review  |  Company News

Cangenix Ltd., Galapagos deal

Galapagos acquired structure-based drug discovery company Cangenix for £1 million ($1.6 million) up front in cash and up to £440,000 ($709,632) in milestones. Cangenix will become part of Galapagos' Argenta service division. Galapagos said the...